Skip to content

Biopsychosocial and Conventional Approach in Bladder Pain Syndrome

Comparison of Biopsychosocial and Conventional Approach in the Treatment of Bladder Pain Syndrome/Interstitial Cystitis

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05155384
Enrollment
60
Registered
2021-12-13
Start date
2021-11-12
Completion date
2022-10-15
Last updated
2022-01-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Pain Syndrome, Interstitial Cystitis

Keywords

chronic pain, pain neuroscience education, Bladder Pain Syndrome, Interstitial Cystitis

Brief summary

The aim of the present study is to compare the effects of biopsychosocial and conventional approach on symptom severity, pain parameters (pain intensity and pain cognitions), disability, psychological distress and quality of life in patients who are suffering from bladder pain syndrome/interstitial cystitis. The study is designed as a randomized clinical trial including two parallel arms. Individuals who meet the inclusion criteria and agree to participate will be randomly assigned into one of the two research arms: biopsychosocial approach group or conventional approach group. A biopsychosocial approach, which is a holistic approach that includes pain neuroscience education, relaxation training and cognitive exercises, will be applied to the patients in the first research arm for the treatment of chronic pain symptoms. For the patients in the second research arm, a conventional approach including pelvic floor stretching exercises and Transcutaneous Electrical Nerve Stimulation (TENS) will be applied for the treatment of chronic pain complaints. Treatments will be lasted for a total of six weeks, with two sessions per week. Participants will be evaluated at the baseline (before treatments) and at the end of the 6th week (after treatments). In the evaluations, information about the demographic and physical characteristics, medical and surgical background, medications and lifestyle characteristics (water, tea, coffee, alcohol, cigarette consumption, the presence constipation and physical activity level) of the individuals will be recorded. For primary or secondary outcome measures, Interstitial Cystitis Symptom and Problem Index, Visual Analog Scale, Pain Catastrophizing Scale, Pain Self-Efficacy Questionnaire, 3-day voiding diary, Pain Disability Index, Hospital Anxiety and Depression Scale, and Short Form-36 will be used. The present study is planned to be carried out with a total of 60 individuals, 30 for each study group based on a sample size analysis. After reaching required sample for the present study, in patients with bladder pain syndrome/interstitial cystitis, the effects of biopsychosocial and conventional approach on symptom and problem severity, pain parameters, disability, psychological status and quality of life will be analyzed using (2\*2) two-way ANOVA.

Interventions

OTHERPain Neuroscience Education

main topics of pain neuroscience education; neurophysiology of the nervous system, protective mechanism of pain, acute pain formation and chronic pain, factors that increase/reduce pain, central sensitization mechanism, neuroplasticity and treatment strategies in chronic pain.

Relaxation exercises are a training based on deep relaxation techniques and visual imagery. Relaxation exercises will be applied at the end of the training sessions.

OTHERCognition target exercise

Cognition target exercises are a time-based approach that is not symptom-conditioned (not based on fatigue or pain). It includes functional and dynamic exercises.

OTHERPelvic floor stretching exercises

Pelvic floor stretching exercises; consists of stretching exercises involving the pelvic floor muscles and surrounding group muscles (such as piriformis, hamstring, adductor group muscles and lumbar extensors).

DEVICETranscutaneous electrical nerve stimulation

It will be used with superficial electrodes attached to the suprapubic region of the patients for 20 minutes in each session.

Sponsors

Hacettepe University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosed with Bladder Pain Syndrome/Interstitial Cystitis * with chronic symptoms (more than 6 months) * Bladder pain severity in the last week should be at least 3/10 according to the Visual Analogue Scale (VAS) * Stable medication schedule * Individuals over the age of 18 (individuals over 65 years of age with a Mini Mental Test score ≥ 24) voluntarily to participate in the study will be included.

Exclusion criteria

* Acute disease state (with ongoing urinary tract infection, active vaginitis, active Herpes infection) * Stones in the bladder, ureter, or urethra in the last 3 months * Having an ulcer appearance on cystoscopy * For women: during pregnancy and/or breastfeeding * Previous history of urological and/or pelvic malignancy * Congenital anomaly of the upper and/or lower urinary tract * who have started a new drug treatment in the last 3 months, or undergoing implantation operation of neuromodulation devices * Diagnosed with opioid dependence * Neurogenic bladder dysfunction or concomitant neurologic conditions * Not cooperating with assessment and/or treatment, and illiterate individuals

Design outcomes

Primary

MeasureTime frameDescription
severity of symptomschange in severity of symptoms from baseline up to end of 6th weekThe Interstitial Cystitis Symptom and Problem Index will be used to assess the severity of symptoms. This scale consists of two separate parts as symptom and problem index, both of which are four questions. Participants will be asked to fill in both parts.

Secondary

MeasureTime frameDescription
Pain cognitionschange in pain cognitions from baseline up to end of 6th weekPain Catastrophizing Scale and Pain Self-Efficacy Questionnaire will be used to assess individuals' cognitions about pain (catastrophizing and self-efficacy).
urinary symptomschange in urinary symptoms from baseline up to end of 6th weekA 3-day voiding diary will be used to evaluate Urinary Symptoms. On this chart, they are asked to record the time they urinate, the amount of urine, the presence of urinary incontinence, the amount and type of fluid consumed.
severity of painchange in severity of pain from baseline up to end of 6th weekPain severity will be evaluated with the Visual Analogue Scale (VAS). Considering the last week, the patients will be asked to mark the severity of pain on a 10-centimeter (cm) straight line, with the starting end as no pain and the ending end as unbearable pain. It will be calculated in cm by measuring the starting tip and the part marked by the patient.
psychological distresschange in psychological distress from baseline up to end of 6th weekThe Hospital Anxiety and Depression Scale will be used to evaluate the psychological distress of individuals. The questionnaire has two sub-dimensions, depression and anxiety.
quality of life of the patientschange in quality of life from baseline up to end of 6th weekQuality of Life will be assessed using the SF-36 scale. Short Form-36 will be used for evaluations. This questionnaire consists of eight different sub-parameters (physical function, physical role difficulty, general health status, pain status, energy/fatigue, social function, emotional role difficulty, and emotional well-being).
severity of disabilitychange in severity of disability from baseline up to end of 6th weekThe Pain Disability Index will be used to question the impact of individuals' daily life due to their pain and the resulting disability.

Countries

Turkey (Türkiye)

Contacts

Primary ContactCeren Gursen, PhD
cerengursen@yahoo.com+905380644120

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 17, 2026